Electrical stimulation based on phase response mapping

• US 8,583,254 B2
• Filed: 12/28/2011
• Issued: 11/12/2013
• Est. Priority Date: 03/19/2010
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Jensen, Steven L., Nelson, Dwight E.
• Primary Examiner(s): MANUEL, GEORGE C
• Application Number:
  US13/338,751
• Publication Number:
  US 20120101547A1
• Time in Patent Office: 685 Days
• Field of Search: 607/62
• US Class Current: 607/62
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/36067 Movement disorders, e.g. tremor or Parkinson disease stimulating motor muscle A61N1/36003
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/36139 with automatic adjustment
• CPC Class Codes: A61N 1/36146 specified by the stimulation parameters

Abstract

This disclosure describes techniques for delivering electrical stimulation at one or more phases relative to an ongoing oscillating signal in a patient, and then mapping the response to the oscillating signal. The techniques may reduce or eliminate the oscillating signal. In one example, the disclosure is directed to a method that includes delivering a set of first electrical stimulation at a plurality of phases relative to an oscillating signal, measuring a response in the oscillating signal to the set of first electrical stimulation after delivering electrical stimulation at each respective phase of the plurality of phases, determining a phase at which to deliver second electrical stimulation based on the measured responses, and delivering the second electrical stimulation to the patient at the determined phase to produce a therapeutic effect.

Claims

1. A method comprising:

delivering a plurality of electrical stimulation pulses at a plurality of different phases relative to an oscillating neurological signal of a patient;

measuring a response in the oscillating neurological signal for each delivery of an electrical stimulation pulse of the plurality of electrical stimulation pulses;

determining a phase response of the patient based on the measured responses; and

delivering a therapy to the patient based on the determined phase response of the patient, wherein each of measuring and determining are performed at least in part by circuitry.

2. The method of claim 1, wherein determining the phase response comprises determining at which different phase of delivery of electrical stimulation most reduces or eliminates the oscillating neurological signal.

3. The method of claim 2, wherein delivering the therapy to the patient based on the determined phase response comprises delivering electrical stimulation at which phase of the oscillating neurological signal electrical stimulation most reduces or eliminates the oscillating neurological signal.

4. The method of claim 1, wherein determining the phase response comprises determining at which different phase of delivery of electrical stimulation the phase of the oscillating neurological signal is advanced or delayed.

5. The method of claim 4, wherein delivering the therapy to the patient based on the determined phase response comprises delivering electrical stimulation at which phase of the oscillating neurological signal electrical stimulation advances or delays the phase of the oscillating neurological signal.

6. The method of claim 1, wherein determining the phase response comprises determining a change in the period of the oscillating neurological signal.

7. The method of claim 1, wherein the oscillating neurological signal oscillates in the beta frequency band.

8. The method of claim 1, wherein determining the phase response of the patient comprises determining a phase response map.

9. The method of claim 1, wherein determining the phase response of the patient comprises identifying a phase transition region.

10. The method of claim 1, wherein the therapy is delivered to address a movement disorder.

11. The method of claim 1, wherein the therapy is delivered to address a seizure disorder.

12. The method of claim 1, further comprising repeating the steps of delivering the plurality of electrical stimulation pulses, measuring the response in the oscillating signal, and determining the phase response at a higher pulse amplitude if the previously determined phase response did not reduce or eliminate the oscillating neurological signal.

13. The method of claim 1, wherein at least one of peak, trough, and half rise of the oscillating neurological signal are used as a reference point for delivering the plurality of electrical stimulation pulses at the plurality of different phases relative to the oscillating neurological signal.

14. A system comprising:

a sensing module;

a stimulation generator;

one or more leads;

one or more electrodes carried by the one or more leads; and

a processor configured to;

control delivery of a plurality of electrical stimulation pulses by the stimulation generator at a plurality of different phases relative to an oscillating neurological signal sensed by the sensing module;

control measurement of a response in the oscillating neurological signal for each delivery of an electrical stimulation pulse of the plurality of electrical stimulation pulses;

control determination of a phase response of the patient based on the measured responses; and

control delivery of a therapy to the patient based on the determined phase response of the patient.

15. The system of claim 14, wherein the processor is configured to determine at which different phase of delivery of electrical stimulation most reduces or eliminates the oscillating neurological signal to determine the phase response.

16. The system of claim 15, wherein the processor is configured to deliver electrical stimulation at which phase of the oscillating neurological signal electrical stimulation most reduces or eliminates the oscillating neurological signal.

17. The system of claim 14, wherein the processor is configured to determine at which different phase of delivery of electrical stimulation the phase of the oscillating neurological signal is advanced or delayed to determine the phase response.

18. The system of claim 17, wherein the processor is configured to deliver electrical stimulation at which phase of the oscillating neurological signal electrical stimulation advances or delays the phase of the oscillating neurological signal.

19. The system of claim 14, wherein the processor is configured to determine a change in the period of the oscillating neurological signal to determine the phase response.

20. The system of claim 14, wherein the processor is configured to determine a phase transition region to determine the phase response.

21. The system of claim 14, wherein the therapy is a movement disorder therapy.

22. The system of claim 14, wherein the therapy is a seizure therapy.

23. The system of claim 14, wherein the processor is configured to control repetition of the steps of delivering the plurality of electrical stimulation pulses, measuring the response in the oscillating signal, and determining the phase response at a higher pulse amplitude if the previously determined phase response did not reduce or eliminate the oscillating neurological signal.

24. The system of claim 14, wherein at least one of peak, trough, and half rise of the oscillating neurological signal are used by the processor as a reference point for delivering the plurality of electrical stimulation pulses at the plurality of different phases relative to the oscillating neurological signal.

25. A device comprising:

means for delivering a plurality of electrical stimulation pulses at a plurality of different phases relative to an oscillating neurological signal of a patient;

means for measuring a response in the oscillating neurological signal for each delivery of an electrical stimulation pulse of the plurality of electrical stimulation pulses;

means for determining a phase response of the patient based on the measured responses; and

means for delivering a therapy to the patient based on the determined phase response of the patient.